$BIOAQ's stock dropped more than 90% today presenting people who had not gotten in the play yet a chance to play a major swing trade for the potential of 200% or more ROI.
Here's why: Many people are suspecting Rick the current CEO to have gone rogue and put out a false PR today given that the company has been in the process of finding bidders to buy it. The PR put out today only has contact info for Rick and all PRs before had contact info for $BIOAQ also the PR stated the company is still in the process of finding buyers to save it giving a two week timeframe from now. Which means in the next two weeks (If the PR is even real and from the company directors and not just something the CEO put out himself without the other directors permission) buyers should be flocking back in taking it up to at least .045 or even .05 with an anticipated high of maybe even .06 if the FOMO is good enough. That being said the news as bad as it was wasn't the worse possible news the company could have gotten, it basically says there is a chance of saving it still, so the drop today was a major overreaction as is expected down here in the OTC.
This morning's Press Release:
BioAmber Provides Update on Sales Process
Jul 30, 2018
MONTREAL, July 30, 2018 /CNW Telbec/ - BioAmber Inc. (OTCPK: BIOAQ) announces that the current stage of the Sales and Investor Solicitation Process (SISP) has concluded without an acceptable offer having been received from a Qualified Bidder as of the due date of July 27, 2018. The company will now seek to obtain court approval to pursue liquidation as well as alternative offers in order to realize the greatest value on behalf of its creditors.
Moving forward, subject to the approval of the court and with support from its monitor or receiver appointed by the court, the company intends to:
•solicit liquidators to bid on the acquisition and disposal of the company's assets, including the Sarnia plant;
•continue to actively engage with Qualified Bidders and other interested parties to determine if, and under what terms, a transaction that would result in the continuation of the company's operations is still possible.
We estimate this process will be conducted over an approximate two-week period with a target conclusion date of August 14. The company will engage with Maynbridge Capital, its interim lender, and all other secured lenders to determine the best going-forward strategy.
"We are clearly disappointed that the Qualified Bidders did not place an acceptable offer for Bioamber," stated Richard Eno, CEO. "We will continue to be actively engaged with potential investors to seek an acceptable transaction and avoid the liquidation of the company's assets. Most importantly, I'd like to thank our dedicated and highly capable employees for their outstanding service to the company."
Potential investors can contact Richard Eno in order to express interest in acquiring the assets or investing in the business.
Note that there can be no guarantee that the company will be successful in securing further financing or achieving its restructuring objectives. Failure by the company to achieve its financing and restructuring goals will likely result in the company and its subsidiaries being liquidated. Liquidation will almost certainly result in no residual value for non-secured creditors and equity investors.
Here's why: Many people are suspecting Rick the current CEO to have gone rogue and put out a false PR today given that the company has been in the process of finding bidders to buy it. The PR put out today only has contact info for Rick and all PRs before had contact info for $BIOAQ also the PR stated the company is still in the process of finding buyers to save it giving a two week timeframe from now. Which means in the next two weeks (If the PR is even real and from the company directors and not just something the CEO put out himself without the other directors permission) buyers should be flocking back in taking it up to at least .045 or even .05 with an anticipated high of maybe even .06 if the FOMO is good enough. That being said the news as bad as it was wasn't the worse possible news the company could have gotten, it basically says there is a chance of saving it still, so the drop today was a major overreaction as is expected down here in the OTC.
This morning's Press Release:
BioAmber Provides Update on Sales Process
Jul 30, 2018
MONTREAL, July 30, 2018 /CNW Telbec/ - BioAmber Inc. (OTCPK: BIOAQ) announces that the current stage of the Sales and Investor Solicitation Process (SISP) has concluded without an acceptable offer having been received from a Qualified Bidder as of the due date of July 27, 2018. The company will now seek to obtain court approval to pursue liquidation as well as alternative offers in order to realize the greatest value on behalf of its creditors.
Moving forward, subject to the approval of the court and with support from its monitor or receiver appointed by the court, the company intends to:
•solicit liquidators to bid on the acquisition and disposal of the company's assets, including the Sarnia plant;
•continue to actively engage with Qualified Bidders and other interested parties to determine if, and under what terms, a transaction that would result in the continuation of the company's operations is still possible.
We estimate this process will be conducted over an approximate two-week period with a target conclusion date of August 14. The company will engage with Maynbridge Capital, its interim lender, and all other secured lenders to determine the best going-forward strategy.
"We are clearly disappointed that the Qualified Bidders did not place an acceptable offer for Bioamber," stated Richard Eno, CEO. "We will continue to be actively engaged with potential investors to seek an acceptable transaction and avoid the liquidation of the company's assets. Most importantly, I'd like to thank our dedicated and highly capable employees for their outstanding service to the company."
Potential investors can contact Richard Eno in order to express interest in acquiring the assets or investing in the business.
Note that there can be no guarantee that the company will be successful in securing further financing or achieving its restructuring objectives. Failure by the company to achieve its financing and restructuring goals will likely result in the company and its subsidiaries being liquidated. Liquidation will almost certainly result in no residual value for non-secured creditors and equity investors.